S&P 500   4,595.68 (+1.39%)
DOW   35,463.80 (+1.24%)
QQQ   372.60 (+1.67%)
AAPL   169.23 (+1.80%)
MSFT   310.68 (+2.42%)
FB   324.78 (+1.62%)
GOOGL   2,745.67 (+1.60%)
AMZN   3,139.63 (+0.44%)
TSLA   1,034.52 (+3.90%)
NVDA   253.88 (+1.28%)
BABA   132.59 (+3.80%)
NIO   30.40 (+6.18%)
AMD   126.71 (-1.22%)
CGC   7.93 (+3.80%)
MU   89.51 (-0.54%)
GE   101.23 (+0.61%)
T   27.31 (+0.11%)
F   22.62 (+0.76%)
DIS   151.47 (+0.91%)
AMC   18.89 (+3.11%)
PFE   53.58 (+0.07%)
ACB   4.98 (+2.47%)
BA   219.92 (+1.31%)
S&P 500   4,595.68 (+1.39%)
DOW   35,463.80 (+1.24%)
QQQ   372.60 (+1.67%)
AAPL   169.23 (+1.80%)
MSFT   310.68 (+2.42%)
FB   324.78 (+1.62%)
GOOGL   2,745.67 (+1.60%)
AMZN   3,139.63 (+0.44%)
TSLA   1,034.52 (+3.90%)
NVDA   253.88 (+1.28%)
BABA   132.59 (+3.80%)
NIO   30.40 (+6.18%)
AMD   126.71 (-1.22%)
CGC   7.93 (+3.80%)
MU   89.51 (-0.54%)
GE   101.23 (+0.61%)
T   27.31 (+0.11%)
F   22.62 (+0.76%)
DIS   151.47 (+0.91%)
AMC   18.89 (+3.11%)
PFE   53.58 (+0.07%)
ACB   4.98 (+2.47%)
BA   219.92 (+1.31%)
S&P 500   4,595.68 (+1.39%)
DOW   35,463.80 (+1.24%)
QQQ   372.60 (+1.67%)
AAPL   169.23 (+1.80%)
MSFT   310.68 (+2.42%)
FB   324.78 (+1.62%)
GOOGL   2,745.67 (+1.60%)
AMZN   3,139.63 (+0.44%)
TSLA   1,034.52 (+3.90%)
NVDA   253.88 (+1.28%)
BABA   132.59 (+3.80%)
NIO   30.40 (+6.18%)
AMD   126.71 (-1.22%)
CGC   7.93 (+3.80%)
MU   89.51 (-0.54%)
GE   101.23 (+0.61%)
T   27.31 (+0.11%)
F   22.62 (+0.76%)
DIS   151.47 (+0.91%)
AMC   18.89 (+3.11%)
PFE   53.58 (+0.07%)
ACB   4.98 (+2.47%)
BA   219.92 (+1.31%)
S&P 500   4,595.68 (+1.39%)
DOW   35,463.80 (+1.24%)
QQQ   372.60 (+1.67%)
AAPL   169.23 (+1.80%)
MSFT   310.68 (+2.42%)
FB   324.78 (+1.62%)
GOOGL   2,745.67 (+1.60%)
AMZN   3,139.63 (+0.44%)
TSLA   1,034.52 (+3.90%)
NVDA   253.88 (+1.28%)
BABA   132.59 (+3.80%)
NIO   30.40 (+6.18%)
AMD   126.71 (-1.22%)
CGC   7.93 (+3.80%)
MU   89.51 (-0.54%)
GE   101.23 (+0.61%)
T   27.31 (+0.11%)
F   22.62 (+0.76%)
DIS   151.47 (+0.91%)
AMC   18.89 (+3.11%)
PFE   53.58 (+0.07%)
ACB   4.98 (+2.47%)
BA   219.92 (+1.31%)
NASDAQ:CTHR

Charles & Colvard, Ltd. Stock Forecast, Price & News

$2.44
-0.02 (-0.81%)
(As of 01/20/2022 10:04 AM ET)
Add
Compare
Today's Range
$2.43
$2.44
50-Day Range
$2.46
$3.32
52-Week Range
$1.31
$3.66
Volume
4,719 shs
Average Volume
77,267 shs
Market Capitalization
$74.22 million
P/E Ratio
5.81
Dividend Yield
N/A
Beta
0.17
30 days | 90 days | 365 days | Advanced Chart
Receive CTHR News and Ratings via Email

Sign-up to receive the latest news and ratings for Charles & Colvard, Ltd. and its competitors with MarketBeat's FREE daily newsletter.


Charles & Colvard, Ltd. logo

About Charles & Colvard, Ltd.

Charles & Colvard Ltd. engages in the manufacture and distribution of moissanite jewels and finished jewelry featuring moissanite for sale in the worldwide jewelry market. It operates through the following business segments: Online Channels and Traditional. The Online Channels segment refers to the e-commerce outlets, including charlesandcolvard.com, third-party online marketplaces, drop-ship, other pure-play, and e-commerce outlets. The Traditional segment consists of wholesale and retail customers. The company was founded in 1995 and is headquartered in Morrisville, NC.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Jewelry, silverware, & plated ware
Sub-Industry
N/A
Current Symbol
NASDAQ:CTHR
Employees
48
Year Founded
N/A

Sales & Book Value

Annual Sales
$39.24 million
Cash Flow
$0.43 per share
Book Value
$1.87 per share

Profitability

Net Income
$12.81 million
Pretax Margin
15.76%

Debt

Price-To-Earnings

Miscellaneous

Free Float
24,697,000
Market Cap
$74.22 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/04/2021
Today
1/20/2022
Next Earnings (Estimated)
2/03/2022
Fiscal Year End
6/30/2022

MarketRank

Overall MarketRank

2.68 out of 5 stars

Consumer Discretionary Sector

67th out of 391 stocks

Jewelry, Silverware, & Plated Ware Industry

1st out of 2 stocks

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 3.1 5 -4 -3 -2 -1 -












Charles & Colvard, Ltd. (NASDAQ:CTHR) Frequently Asked Questions

Is Charles & Colvard, Ltd. a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Charles & Colvard, Ltd. in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Charles & Colvard, Ltd. stock.
View analyst ratings for Charles & Colvard, Ltd.
or view top-rated stocks.

How has Charles & Colvard, Ltd.'s stock been impacted by Coronavirus?

Charles & Colvard, Ltd.'s stock was trading at $0.7553 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CTHR shares have increased by 223.1% and is now trading at $2.44.
View which stocks have been most impacted by COVID-19
.

When is Charles & Colvard, Ltd.'s next earnings date?

Charles & Colvard, Ltd. is scheduled to release its next quarterly earnings announcement on Thursday, February 3rd 2022.
View our earnings forecast for Charles & Colvard, Ltd.
.

How were Charles & Colvard, Ltd.'s earnings last quarter?

Charles & Colvard, Ltd. (NASDAQ:CTHR) announced its quarterly earnings results on Thursday, November, 4th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.02 by $0.01. The firm had revenue of $10.28 million for the quarter, compared to the consensus estimate of $9.20 million. Charles & Colvard, Ltd. had a trailing twelve-month return on equity of 24.90% and a net margin of 30.69%. During the same period last year, the company earned $0.03 EPS.
View Charles & Colvard, Ltd.'s earnings history
.

What price target have analysts set for CTHR?

1 analysts have issued 1-year target prices for Charles & Colvard, Ltd.'s shares. Their forecasts range from $3.75 to $3.75. On average, they expect Charles & Colvard, Ltd.'s share price to reach $3.75 in the next year. This suggests a possible upside of 53.7% from the stock's current price.
View analysts' price targets for Charles & Colvard, Ltd.
or view top-rated stocks among Wall Street analysts.

Who are Charles & Colvard, Ltd.'s key executives?

Charles & Colvard, Ltd.'s management team includes the following people:
  • Don O'Connell, President, Chief Executive Officer & Director
  • Clint J. Pete, Chief Financial Officer & Treasurer

What other stocks do shareholders of Charles & Colvard, Ltd. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Golar LNG Partners (GMLP), Novan (NOVN), OrganiGram (OGI), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Zosano Pharma (ZSAN) and Aeterna Zentaris (AEZS).

What is Charles & Colvard, Ltd.'s stock symbol?

Charles & Colvard, Ltd. trades on the NASDAQ under the ticker symbol "CTHR."

Who are Charles & Colvard, Ltd.'s major shareholders?

Charles & Colvard, Ltd.'s stock is owned by a number of institutional and retail investors. Top institutional shareholders include Carroll Financial Associates Inc. (0.03%). Company insiders that own Charles & Colvard, Ltd. stock include Clint J Pete, Don O'connell and Ollin B Sykes.
View institutional ownership trends for Charles & Colvard, Ltd.
.

Which major investors are selling Charles & Colvard, Ltd. stock?

CTHR stock was sold by a variety of institutional investors in the last quarter, including Carroll Financial Associates Inc..
View insider buying and selling activity for Charles & Colvard, Ltd.
or view top insider-selling stocks.

How do I buy shares of Charles & Colvard, Ltd.?

Shares of CTHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Charles & Colvard, Ltd.'s stock price today?

One share of CTHR stock can currently be purchased for approximately $2.44.

How much money does Charles & Colvard, Ltd. make?

Charles & Colvard, Ltd. has a market capitalization of $74.22 million and generates $39.24 million in revenue each year. The company earns $12.81 million in net income (profit) each year or $0.42 on an earnings per share basis.

How many employees does Charles & Colvard, Ltd. have?

Charles & Colvard, Ltd. employs 48 workers across the globe.

What is Charles & Colvard, Ltd.'s official website?

The official website for Charles & Colvard, Ltd. is www.charlesandcolvard.com.

Where are Charles & Colvard, Ltd.'s headquarters?

Charles & Colvard, Ltd. is headquartered at 170 SOUTHPORT DRIVE, MORRISVILLE NC, 27560.

How can I contact Charles & Colvard, Ltd.?

Charles & Colvard, Ltd.'s mailing address is 170 SOUTHPORT DRIVE, MORRISVILLE NC, 27560. The company can be reached via phone at (919) 468-0399, via email at [email protected], or via fax at 919-468-0486.


This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.